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Abstract 
Objective: to investigate whether harmine has a promotive effect on human periodontal 
ligament cells (hPDLCs)-induced tissue regeneration. 
Materials and Methods: Various concentrations of harmine on hPDLCs proliferation were 
tested. Osteogenic and cementogenic characteristics were examined in hPDLC/rhBMP-2 and 
hPDLC/harmine by alizarin red S staining, real-time PCR, and Western blotting assay. The 
activity of harmine was investigated in an ectopic transplantation nude mouse model. 
Results: We determined that 10 µM of harmine was the threshold concentration. 
hPDLC/harmine showed similar mineralized nodule formation in alizarin S staining 
compared to hPDLC/rhBMP-2. In real-time PCR, a highest gene expression level was 
observed for Runx2 in hPDLC/harmine at all time points. The level of CEMP-1 in 
hPDLC/harmine was higher at 7days than hPDLCs alone. Thicker band of Runx2 in 
hPDLC/harmine was observed than in hPDLC/rhBMP-2 at 7 days by Western blotting. The 
band for CEMP-1 in hPDLC/harmine was thicker than hPDLCs alone at both 7 and 14 days. 
In ectopic transplantation, hPDLCs with harmine showed a comparable amount of 
mineralized tissue formation compared to rhBMP-2. hPDLCs with harmine or rhBMP-2 
formed both bone and cementum-like tissue with Sharpey`s fiber-like collagen insertion. 
Conclusion: Harmine can be a potential candidate for promoting hPDLCs-induced tissue 
regeneration. 
  
Introduction 
 Periodontitis, one of the most widespread diseases worldwide, involves loss of tooth-
supporting structures in varying degrees and may cause loss of tooth, which deteriorates the 
quality of life (Cunha-Cruz et al., 2007). Considering the age-related prevalence of 
periodontitis, managing this disease has become increasingly important in the current aged 
and ultra-aged populations (Kassebaum et al., 2014). 
 
 Non-surgical, surgical and antimicrobial approaches or a combination of these approaches 
are conventional modes for resolution of periodontitis in a routine clinical setting (Dentino et 
al., 2013). Disappointingly, while these methods are effective for controlling periodontal 
disease, they are not sufficient for predictably achieving regeneration (Zeichner-David, 2006). 
Thus, various bioactive agents have been extensively explored. Growth factors, such as 
fibroblast growth factor-2, platelet-derived growth factor-BB and growth/differentiation 
factor-5 have been shown to have favorable preclinical and clinical results (Cochran et al., 
2016, Lee & Wikesjo, 2014, Nevins et al., 2005, Takayama et al., 2001), but they are still not 
a commonly used modality. Enamel matrix derivative has also been extensively investigated 
(Miron et al., 2016). Numerous studies have supported the regenerative outcome of enamel 
matrix derivative, but its effect has only been validated in limited environments (Miron et al., 
2016). Moreover, folk medicine using natural compounds has driven the interest in 
periodontal regeneration; however, the number of studies is relatively insufficient.   
 
 β-carboline alkaloids, such as harmine, harmol, harmane, harmaline, harmalol, are of 
interest due to a large variety of pharmacologic effects (Allen & Holmstedt, 1980, Cao et al., 
2007). They are found in several plants, such as Apocynaceae, Elaeagnaceae, Leguminosae, 
Passifloraceae and Zygophyllaceae, and are empirically used as medicinal substances from 
the past: emmenagogue and abortifacient in the Middle East and North Africa, hallucinogenic 
in the Amazon, and a cure for gastrointestinal tract cancer and malaria in northwest China 
(Cao et al., 2007). In line with the above usage, many pharmacologic properties have been 
identified, such as monoamine oxidase inhibitory, vasorelaxant, antioxidation, and 
antimutagenic effects (Berrougui et al., 2006, Kim et al., 1997, Moura et al., 2007). Recently, 
the inhibition of osteoclast differentiation and the promotion of osteoblast differentiation have 
been serially demonstrated as effect of harmine, one of the β-carboline alkaloids (Yonezawa 
et al., 2011a, Yonezawa et al., 2011b). Interestingly, the bone anabolic effect of harmine may 
be derived from a structural difference with other β-carboline alkaloids and such an effect is 
not correlated with other pharmacologic actions. In this context, harmine can be a promising 
cue for periodontal tissue regeneration. 
 
 To the best of our knowledge, there has been little evidence to date that harmine could be 
used for the regeneration of tooth-supporting structures. The aim of the present study was to 
investigate whether harmine has a promotive effect on human periodontal ligament cells 
(hPDLCs)-induced tissue regeneration in vitro and in vivo. 
 
 
Materials and Methods 
Periodontal ligament cells (PDLCs) isolation 
 The study protocol for PDL cell isolation was approved by the Ethics Committee of Inha 
Hospital (Approval No. IUH IRB 11-32). Informed consent was obtained from a healthy 
candidate scheduled for third molar extraction. The isolation process for human PDLCs 
(hPDLCs) was described in a previous study (Jung et al., 2013, Kim et al., 2016, Prince et al., 
2001). PDLCs were obtained from the third molar extracted from systemically healthy donor 
with no history of smoking. The extracted third molar was washed using α-minimum essential 
medium (Gibco, Grand Island, NY) containing 100 U/mL penicillin and 100 mg/mL 
streptomycin. The middle 1/3- apical 1/3 of root surface was scraped to obtain PDL tissues. 
Then, the tissue was minced, and digested with 2 mg/mL collagenase (Waco Pure Chemical 
Industries, Tokyo, Japan) and 1 mg/mL dispase (Gibco) four times at an interval of 20 
minutes at 37°C. The collected cells were seeded into a T75 cell culture flask (BD Falcon 
Labware, Franklin Lakes, NJ) and cultured in a growth medium comprising α-minimum 
essential medium (Gibco), 15% fetal bovine serum (Gibco), 2mM L-glutamine (Gibco), 100 
µM ascorbic-acid-2-phosphate (Sigma-Aldrich, St. Louis, MO), 100 U/mL penicillin, and 
100 mg/mL streptomycin (Gibco) at 37°C in a humidified atmosphere of 5% CO2. The media 
was refreshed every 3 to 4 days. Cells at passages five were used in following experiments 
for the present study. The stemness of the cells used in the present study was already verified 
in our previous studies using same cells (Jung et al., 2013, Jung et al., 2014). In those studies, 
similar expression of stem cell surface markers, such as CD44, CD105, CD146, STRO-1 
were detected by flow cytometry. 
 
Cell proliferation at various concentrations of harmine (MTT assay) 
 hPDLCs were plated at 8.0×103 into 24-well plates, and cultured in a growth medium 
containing different concentrations of harmine (0, 1, 2.5, 5, 10, 20 and 40 µM) (Wako) for 3, 
7 and 14 days, respectively. Cellular activity was evaluated using 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) solution (0.5 mg/mL) (Amresco, Solon, 
OH). Following a 3-hour incubation, the supernatant was removed and cells were treated with 
dimethyl sulfoxide (Amresco). Optical densities were measured at 540 nm using a microplate 
reader (Molecular Devices, Sunnyvale, CA).  
 Osteogenic and cementogenic induction of hPDLC/BMP-2 and hPDLC/harmine 
Mineralized nodule formation 
hPDLCs (5 x 104 cells/well) were cultured in 24-well plates with an osteogenic 
differentiation medium containing either 100 ng/mL of rhBMP-2 (Novosis, Daewoong, Seoul, 
Korea) (hPDLSC/BMP) or 10 uM of harmine (hPDLSC/Har) for 14 and 28 days. The 
osteogenic differentiation medium comprised a growth medium containing 10-8M 
dexamethasone (Sigma-Aldrich) and 50 µg/ml ascorbic acid (Gibco) and 10 mM β-
glycerophosphate (Gibco), and was refreshed every 3 days. After the cellular matrices were 
rinsed with PBS, they were fixed with 4% paraformaldehyde for 10 minutes, and then stained 
with 2% alizarin red S (pH 7.2) (Sigma-Aldrich) for 1 hour. Stained nodules were observed 
with a light microscope (Olympus CK41; Olympus Optical, Tokyo, Japan). The stained 
nodules were washed with PBS and treated with 10% cetylpyridinium chloride (1 mL/well) 
overnight to extract the staining agent. Then, the optical density of each group was measured 
at 540 nm using a microplate reader. 
 
Real-time polymerase chain reaction (PCR) for osteogenic and cementogenic markers  
 hPDLCs (2x105 cells/well) were cultured in 6-well plates with a growth medium containing 
50 µg/ml ascorbic acid (Gibco) and 10 mM β-glycerophosphate (Gibco). Either 100 ng/mL of 
rhBMP-2 or 10 uM of harmine was also added in the medium. The cell culture was 
performed for 1, 3, 7 and 10 days. The total RNA was isolated using the TRIzol reagent 
(Invitrogen, Carlsberg, CA) and cDNA was synthesized with an oligo (dT) primer (Maxime 
RT Premix; iNtRon Biotechnology, Daejeon, Korea). Real-time PCR was performed with the 
SYBR Green Master Mix (Applied Biosystems, Carlsbad, CA) in the StepOnePlus real-time 
PCR system (Applied Biosystems) in triplicate. The PCR amplification was conducted using 
the following target gene markers (Supplement 1): alkaline phosphatase (ALP), osteocalcin 
(OCN), Runt-related transcription factor 2 (Runx2) and cementum protein 1 (CEMP1). The 
relative mRNA expression of the above genes was calculated by comparison to the reference 
(GAPDH). 
 
Western blotting 
 Western blotting was performed for CEMP1, ALP, Runx2 and OCN. hPDLCs (4x105 
cells/well) were cultured in a 60-mm dish with a growth medium containing 50 µg/ml 
ascorbic acid (Gibco) and 10 mM β-glycerophosphate (Gibco) for 7 and 14 days. In the 
medium, either 100 ng/mL of rhBMP-2 or 10 uM of harmine was supplemented. M-PER 
mammalian protein extraction reagent (Thermo Scitific, Odessa, TX, USA) was used for the 
extraction of proteins. The protein concentration of the lysates was determined using the 
Pierce BCA protein assay kit (Thermo Scitific). Following boiling for 10 min, 30 µg of 
protein from each day was loaded on 10% sodium dodecyl sulfate (SDS) polyacrylamide gel 
electrophoresis (PAGE) with molecular weight marker, and separated by electrophoresis. 
Then the proteins were transferred to polyvinylidene diﬂuoride (PVDF) membranes, followed 
by blocking for 60 min at room temperature in 0.1% Tween 20-Tris-buffered saline 
containing 5% skim milk, and incubating overnight at 4°C with anti-OCN (diluted 1:1,000, 
Santa Cruz Biosciences, Texas, USA), anti-Runx2 (diluted 1:2000, Abcam Ltd), anti-
CEMP1(diluted 1:1000, Santa Cruz Biosciences), anti-ALP (diluted 1:1000, Santa Cruz 
Biosciences), and anti-β-actin (Santa Cruz Biosciences) antibodies. The membranes were 
washed with 0.1% Tween 20-Tris-buffered saline three times for 5 min, and then the 
membranes were incubated with donkey anti-goat horseradish peroxidase (HRP)-conjugated 
antibody for CEMP1 (diluted 1:10,000, Santa Cruz Biosciences), goat anti-rabbit HRP-
conjugated antibody for ALP, OCN and Runx2 (diluted 1,10,000, Santa Cruz Biosciences), 
goat anti-mouse HRP-conjugated antibody for β-actin (diluted 1:10,000, Santa Cruz 
Biosciences) at room temperature for 1 hour. The chemiluminescent reagent (Amersham Life 
Science) was applied and exposed to X-ray film (AGFA, Belgium). 
 
Subcutaneous ectopic transplantation 
All procedures for animal experiments were approved by the Institutional Animal Care and 
Use Committee of Inha University (Approval No.: INHA 140801-322). Twenty 
immunocompromised mice (6-week-old Balb/c nude mice, OrientBio, Sungnam, Korea) were 
used for ectopic transplantation. Eighty milligrams of biphasic calcium phosphate (BCP; 
MBCP Plus, Biomatlante, Bretagne, France) was used for the cell carrier. In all animals, three 
dorsal sites were selected and assigned as follows (n=5 per group):  
Group1. BCP carrier only (BCP). 
Group 2. BCP carrier-loaded rhBMP-2 (BCP/BMP). 
Group 3. hPDLCs seeded on a BCP carrier (BCP/hPDLC). 
Group 4. hPDLCs seeded on a rhBMP-2-loaded BCP carrier (BCP/hPDLC/BMP). 
Group 5. BCP carrier-loaded harmine (BCP/Har).  
Group 6. hPDLCs seeded harmine-loaded BCP carrier (BCP/hPDLC/Har). 
 
 The BCP carrier was incubated in PBS only, 1 µg of rhBMP-2 in PBS (Jung et al., 2014), 
and 16.98 µg of harmine in PBS overnight at 37°C. The loading amount of harmine was 
determined by the threshold concentration from MTT assay (10 µM) and the released amount 
measured from the in vitro releasing assay using ultra performance liquid chromatography. In 
the releasing assay, it was estimated that 10 uM (2.25 ug/ml) harmine would be released from 
16.98 µg of harmine loaded onto 80 mg BCP (data are not shown). Before transplantation, 
hPDLCs (1 x 106 cell/ carrier) were seeded on the carrier for Groups 3, 4 and 6, and 
incubated for 2 hours. Then, the assigned combination of BCP carrier, either hPDLCs or not, 
and either rhBMP-2 or harmine or not was transplanted in the subcutaneous area of the 
dorsum in mice. The animals were sacrificed 2 or 8 weeks postsurgery. 
 
Histologic & histomorphometric analysis 
 The explanted specimens were fixed in 10% formalin, decalcified with 10% EDTA solution 
containing 1% paraformaldehyde, embedded in paraffin, and then sectioned at a thickness of 
4 µm. After deparaffinization, the specimens were stained with hematoxylin–eosin and Picro-
Sirius red, and were examined using a binocular microscope (Leica DM LB; Leica 
Microsystems, Wetzlar, Germany). Images of the specimens were captured and saved 
(cellSens Standard 1.11; Olympus Corporation, Center Valley, PA, USA). Newly formed 
mineralized tissue was measured using automated image analysis software (Photoshop CS6; 
Adobe Systems, San Jose, CA, USA). The percentage of newly formed mineralized tissue 
was calculated against the total augmented area. The histomorphometric analysis was 
performed by a single experienced investigator (H.C.L) who was blinded from the group 
allocation. 
 
Statistical analysis 
 A software package was used for statistical analysis (SPSS ver. 21.0, IBM Corporation, 
Armonk, NY, USA). Shapiro-Wilk tests were performed for normal distribution of the data. 
Then, either ANOVA and Student`s t test or Kruskal-Wallis test and Mann-Whitney U test 
were used. For post-hoc multiple comparison, Tukey tests for ANOVA or Dunn`s test for 
Kruskal-Wallis test was used. The level of statistical significance was set at P<0.05. 
 
 
Results 
Effect of harmine concentration on hPDLCs 
With 0 to 10 µM of harmine, cell proliferation significantly increased with time (P<0.05). 
There was no statistically significant difference among corresponding time points for 0 to 10 
µM. However, at 20 µM, statistically low cell proliferation was observed at 7 and 14 days, 
compared with the lower concentrations. Moreover, the proliferation at 7 and 14 days was 
significantly decreased compared to that at 3 days, and the same results were observed with 
40 µM (Fig. 1). Thus, 10 µM harmine is suspected to be the threshold value, so we used 10 
µM harmine for further assays. 
 
Osteogenic and cementogenic characteristics of hPDLC/BMP-2 and hPDLC/harmine 
(alizarin red S staining, real-time PCR, and Western blotting) 
 In alizarin red S staining, the amount of mineralization at 14 days was not significantly 
different among hPDLCs, hPDLC/Har and hPDLC/BMP. The mineralization in hPDLC/Har 
and hPDLC/BMP at 28 days significantly increased compared to 14 days, and was 
significantly greater than that of hPDLCs alone. There was no statistical difference between 
hPDLC/Har and hPDLC/BMP at 28 days (Fig. 2).  
  
 In real-time-PCR, a highest gene expression level was observed for Runx2 in hPDLC/Har at 
3, 7, 10 days. At 3 days, the level of Runx2 in hPDLC/Har was statistically higher compared 
to hPDLC/BMP. At 7 and 10 days, the level of Runx2 in hPDLC/Har was statistically higher 
than hPDLCs alone. The level of OCN in hPDLC/Har increased more than twofold at 7 days 
compared to hPDLCs alone, but it was not statistically different. Also, the level of CEMP-1 
became higher at 7 days than hPDLCs alone, but it did not reach statistical difference (Fig. 
3A). 
  
 In Western blot assay, the bands for Runx2 were thicker in hPDLC/Har than hPDLCs alone 
at both 7 and 14 days. At 7 days, the band for Runx2 in hPDLC/Har was thicker compared to 
hPDLC/BMP. The bands for OCN and CEMP-1 in hPDLC/Har were thicker than hPDLCs 
alone at both 7 and 14 days (Fig. 3B). 
 
Histologic and histomorphometric analyses of ectopic transplantation  
Histologic observation at 2 weeks 
 In Group 1 (BCP), no mineralized tissue was observed. BCP particles were surrounded by 
loose connective tissue and a few inflammatory cells. In Group 2 (BCP/BMP), immature 
mineralized tissue and osteoid-like structure was observed on some of BCP particles with 
randomly oriented connective tissue. In Group 3 (BCP/hPDLC), a little mineralized tissue 
was seen in two specimens, but in Group 4 (BCP/hPDLC/BMP), the apposition of 
mineralized tissue on the particles was frequently observed in all specimens, and periodontal 
ligament (PDL)-like fibers were also found. In Group 5 (BCP/Har), mineralized tissue was 
rarely observed, and multinucleated giant cells were frequently observed in the connective 
tissue area. In Group 6 (BCP/hPDLC/Har), an increased amount of immature and osteoid-like 
mineralized tissue was formed compared to Group 5. PDL-like fibers were observed around 
the immature mineralized tissue. Multinucleated cells were also observed, but fewer were 
present in comparison to Group 5 (Fig. 4A-L).  
 
Histologic observation at 8 weeks 
 In the group 1, there was no sign of mineralization. Many blood vessels and various 
densities of connective tissue were observed. In Group 2, bone tissues with osteoblasts, 
osteocytes and reversal lines were observed with abundant fatty marrow. In Group 3, 
mineralized tissues were observed on a few BCP particles and Sharpey`s fiber-like collagen 
bundles were found around some mineralized tissue. Group 4 demonstrated the greatest 
amount of mineralized tissue. Bone tissues lining osteoblasts and containing osteocytes were 
commonly found around BCP particles, and cementum-like tissue with Sharpey`s fiber-like 
collagen insertion was also observed. Various amount of fatty marrow formation was 
observed in the specimens of Group 4. In Group 5, the presence of mineralized tissue was 
limited and dense connective tissue filled in the intergranular space. Multinucleated giant 
cells were observed like the finding at 2 weeks, but the amount decreased. In Group 6, two 
different mineralized patterns were found like in Group 4: bone tissue with randomly-
oriented collagen fiber and cementum-like tissue inserted by Sharpey`s fiber-like structure. 
However, cementum-like tissue was more frequently observed compared to in Group 4. 
Varying degrees of fatty marrow formation were observed among the specimens in Group 6 
(Fig. 4M-X).  
Picro-Sirius red staining was performed for Groups 4 and 6 for orientation of collagen fiber 
near the mineralized tissue. Parallel-oriented and perpendicularly-inserted collagen fibers 
were observed near mineralized tissue in both groups. In Group 6, more intensive insertion of 
perpendicular fibers was observed, as compared to the group 4 (Fig. 5). 
 
Histomorphometry 
At 2 weeks, the amount of mineralized tissue was the greatest in Group 4, followed by 
Groups 6, 2, 5, 3 and 1. Compared to Groups 1, 4 and 6 demonstrated statistically greater 
mineralization (P<0.05). Group 4 showed statistically greater mineralization than Group 3. At 
8 weeks, the greatest mineralization was observed in Group 4, and mineralization of Group 2 
and 6 were comparable. Groups 2, 4 and 6 had statistically greater mineralization than group 
1. Group 2 and 6 showed approximately ten-fold more mineralization than Groups 3 and 5, 
but statistical significance was not found. Group 4 had statistically greater mineralization 
compared to Group 3 (Fig. 6, Table 1). 
 
 
Discussion 
 The present study investigated whether harmine is a candidate for tissue regeneration using 
PDL cells, focused on periodontal regeneration. It was previously demonstrated that harmine 
has bone anabolic effect (Yonezawa et al., 2011a, Yonezawa et al., 2011b), but it has yet to 
reveal the effect of harmine on periodontal regeneration. Harmine treatment in vitro 
significantly increased mineralization nodule formation and Runx2 expression. An increase 
of CEMP-1 was shown, but it was not statistically significant. In the transplantation model of 
rats, hPDLCs with harmine increased not only bone-like but also cementum-like 
mineralization. Specifically, cementum-like hard tissue embedded Sharpey`s fiber-like 
collagen fibers was more frequently observed when PDL cells was supplemented by harmine 
than by rhBMP-2. 
 
 The effective concentration of harmine for hPDLCs has yet to be determined because the 
present study is the first to investigate the effect of harmine on hPDLCs. In MTT assay, cell 
toxicity was not found up to 10 µM of harmine, but cell proliferation was significantly 
diminished at 20 µM. In previous studies, the effect of harmine concentration was also 
investigated for bone-anabolic purposes. Yonezawa et al. demonstrated that harmine 
decreased TRAP activity dose dependently up to 10 µM for RAW264.7 cells, and 3 µM 
almost completely inhibited multinucleated osteoclast formation (Yonezawa et al., 2011a). In 
the following study, a dose-dependent increase in the intensity of ALP, alizarin S and von 
Kossa staining was observed for up to 10 µM of harmine in MC3T3-E1 cells, and a similar 
trend in ALP activity was observed in C3H10T1/2 cells (Yonezawa et al., 2011b). Thus, we 
determined that 10 µM is a threshold for periodontal regeneration. However, it should be 
noted that smaller concentration of harmine was not tested for mineralization with PDLCs.  
 
 One important finding from the previous study was that ALP activity was enhanced by 
harmine treatment in both mesenchymal cells (C3H10T1/2) and osteoblast precursor cells 
(MC3T3-E1) (Yonezawa et al., 2011b). These results demonstrate that harmine not only 
increases the function of osteoblastic lineage cells, but also differentiates mesenchymal cells 
into mineralized tissue forming cells, which suggests that harmine is a potential 
osteoinductive agent. In the present study, harmine was compared with rhBMP-2. In 
mineralized nodule formation shown by Alizarin S staining, there was no statistical difference 
between harmine and rhBMP-2. In real-time PCR, only Runx2 gene in hPDLCs/Har was 
statistically greater than other groups, but the increased expression of Runx2 from 3 days 
indicated that osteoblastic cascade had been already initiated because Runx2 is major 
transcription factor for osteoblastic differentiation (Prince et al., 2001). Such may be also 
related with an insignificantly increased level of OCN at 7days in hPDLC/Har (real-time 
PCR) and thicker bands of ALP, OCN in hPDLC/Har than in hPDLC only (Western blotting). 
In ectopic transplantation model, Group 6 (BCP/hPDLC/Har) enhanced mineralized tissue 
formation, and the amount of mineralization was statistically comparable to Group 2 
(BCP/BMP) and 4 (BCP/hPDLC/BMP). Considering the above findings, harmine could be 
regarded as an effective stimulant for increasing mineralization from the target cells. 
 
One may argue that the capacity of harmine as a direct inducer for mineralization is 
insufficient, because there was little effect on mineralized tissue formation when it was used 
alone (Group 5). However, it was hard to say that the mineralization without target cells is 
surely advantageous. If some effects, e.g. mineralization is generated by a certain biomaterial 
in the absence of the target cells, the consequence may be unwanted tissue formation in the 
unwanted location. Therefore, in other way around, the stimulating action of harmine in the 
presence of the target cells may be regarded to be more desirable although it leaves room for 
further discussion on which is a better mode for the regeneration in terms of the presence or 
absence of target cells. 
 
 In Groups 3, 4 and 6, cementum-like mineralized tissue with Sharpey`s fiber-like collagen 
bundle was observed, which may be related to the finding that there was an increase of 
CEMP-1 in real-time PCR and Western blot assays in both rhBMP-2- and harmine-treated 
groups. CEMP-1 is specifically expressed by cementoblasts and PDL cells (Alvarez et al., 
2007, Arzate et al., 2002). Overexpression of CEMP-1 improves cementoblast differentiation 
during the differentiation of periodontal ligament cells, but reduced osteoblast differentiation 
(Komaki et al., 2012). Notably enough, when hPDLCs were treated with harmine (Group 6), 
the development of such cementum-resembling structures was more frequently found 
compared to hPDLCs treated with rhBMP-2; Sharpey`s fiber-like collagen bundles were 
more intensively observed under Picro-Sirius red staining in Group 6. As described earlier, 
harmine significantly activated Runx2 compared to rhBMP-2, which was in line with the 
previous study (Yonezawa et al., 2011b). Even though Runx2 is known as a specific regulator 
of osteoblast differentiation, it was also observed that immunoreactivity of Runx2 was 
detected in acellular/cellular cementum formation (Hirata et al., 2009). Thus, it can be 
conjectured that the effect of harmine on hPDLCs is not oriented only in bone formation, 
rather dual activation in both cementum and bone formation compared to rhBMP-2. 
 
 As in the rhBMP-2-treated groups, fatty marrow formation was observed in Group 6. It is 
well-known that BMP-2 stimulate adipogenesis as well as osteogenesis (Zara et al., 2011). It 
has been demonstrated that harmine induces BMPs expression and activates BMP pathway 
(Yonezawa et al., 2011b), which may indicate that harmine could induce fatty marrow 
formation like BMP-2.  
 
 Multinucleated giant cells were frequently observed in Groups 5 and 6 at 2 weeks in vivo 
compared to other groups. Even though MTT assay demonstrated that 10 µM is a threshold 
concentration for hPDLCs in vitro, in vivo application may result in somewhat different 
consequences because various cells interplay in an in vivo environment. Meanwhile, Group 6 
showed fewer multinucleated cells compared to Group 5, which was in accordance with 
results from previous studies reporting the immunosuppressive effect of stem cells (Jung et 
al., 2014, Le Blanc et al., 2003, Wada et al., 2009). Moreover, lower concentrations of 
harmine (<10 µM) were not tested for mineralization in the present study, and the comparison 
with 1 µg of rhBMP-2 might be questioned even though it is the known positive control from 
our previous study (Jung et al., 2014). Considering the above, further investigation about 
different concentrations should be performed for optimization. 
 
 Some concerns can be logically raised about the application of harmine because it has 
several other pharmacologic actions. It has been suggested that the bone anabolic effects of 
harmine are not affected by the presence of antagonists or agonists to receptors for exerting 
other activities (Yonezawa et al., 2011b). Such a finding may indicate that harmine delivery 
could provoke several events simultaneously and careful evaluation using preclinical models 
is further required.  
 
 PDLC is known to consist of several phenotypes, such as cementoblast-like and/or 
osteoblast-like properties (Marchesan et al., 2011). In the present study, harmine enhanced 
mineralization with hPDLCs in vitro and in vivo, and the mineralized tissue included both 
bone and cementum-like tissues, which is attributable to possibly Runx2 activation. The 
present study was the fisrt step for extracting potential candidate of periodontal regeneration, 
and should be further supported by preclinical studies with experimentally induced 
periodontal defect.  
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Figure legends 
Figure 1. Cell proliferation for different concentrations of harmine (MTT assay).  
*Significantly different compared to 3 days at the same concentration 
†Significantly different compared to 7 days at the same concentration 
‡Significantly different compared to corresponding time points for each concentration  
 
Figure 2. Mineralized tissue formation capability of hPDLCs, hPDLCs/harmine (hPDLC/Har) 
and hPDLCs/rhBMP-2 (hPDLC/BMP). A) Representative images of alizarin red S staining 
following osteogenic differentiation. B) Quantitative analysis of mineralized nodule 
formation. The amount of mineralization was significantly greater in hPDLC/Har and 
hPDLC/BMP than hPDLCs at 28 days. No statistical difference was noted between 
hPDLC/Har and hPDLC/BMP.  
*Statistically significant compared to 14 days 
†Statistically significant compared to hPDLCs 
 
Figure 3. The results of real-time PCR and Western blot assay for hPDLCs, hPDLCs/harmine 
(hPDLC/Har) and hPDLCs/rhBMP-2 (hPDLC/BMP). 
A) Relative gene expression of alkaline phosphatase (ALP), osteocalcin (OCN), Runt-related 
transcription factor 2 (Runx2) and cementum protein 1 (CEMP1) in hPDLCs, hPDLC/Har 
and hPDLC/BMP quantified by real-time PCR. Runx2 in hPDLC/Har was statistically higher 
at 3days compared to hPDLC/BMP, and was statistically higher at 7 and 10 days than 
hPDLCs alone. CEMP-1 in hPDLC/Har became insignificantly higher at 7 days than 
hPDLCs alone. B) Expression level of ALP, OCN, Runx2 and CEMP1 proteins in hPDLCs, 
hPDLC/Har and hPDLC/BMP by Western blot. The thickness of bands in Runx2 stood out in 
hPDLC/Har at both 7 and 14 days. The bands for OCN and CEMP-1 in hPDLC/Har were 
thicker than hPDLCs alone at both 7 and 14 days. 
‡Statistically significant compared to hPDLCs/Har 
 
Figure 4. Histologic observation of ectopic transplantation model. A-F) Observation at 2 
weeks with magnification x 100. G-L) Observation at 8 weeks with magnification x 400. M-
R) Observation at 8 weeks with magnification x 100. S-X) Observation at 8 weeks with 
magnification x 400. Arrowhead, cementum-like tissue having Sharpey`s fiber-like collagen 
fiber insertion; Arrow, multinucleated giant cells; NM, newly-formed non-mineralized tissue; 
NB, new bone; BM, bone marrow; BCP, biphasic calcium phosphate (BCP) carrier only; 
BCP/BMP, BCP carrier-loaded rhBMP-2; BCP/hPDLC, hPDLCs seeded on a BCP carrier; 
BCP/hPDLC/BMP, hPDLCs seeded on a rhBMP-2-loaded BCP carrier; BCP/Har, BCP 
carrier-loaded harmine; BCP/hPDLC/Har, hPDLC-seeded harmine-loaded BCP carrier. 
 
Figure 5. Histologic observation using Picro-Sirius red staining. A-C) BCP/hPDLC/BMP, 
hPDLCs seeded on a rhBMP-2-loaded biphasic calcium phosphate (BCP) carrier. D-F) 
BCP/hPDLC/Har, hPDLC-seeded harmine-loaded BCP carrier. A, D) original magnification 
x 100. B, C, E, F) original magnification x 400. Arrow head, cementum-like mineralized 
tissue with Sharpey`s-like fiber insertion; NB, new bone; BM, bone marrow. 
 
Figure 6. Histomorphometric analysis of ectopic transplantation. BCP, biphasic calcium 
phosphate (BCP) carrier only; BCP/BMP, BCP carrier-loaded rhBMP-2; BCP/hPDLC, 
hPDLCs seeded on a BCP carrier; BCP/hPDLC/BMP, hPDLCs seeded on a rhBMP-2-loaded 
BCP carrier; BCP/Har, BCP carrier-loaded harmine; BCP/hPDLC/Har, hPDLC-seeded 
harmine-loaded BCP carrier. 
*Statistically significant compared to BCP 
†Statistically significant compared to BCP/hPDLC 
‡Statistically significant compared to 2 weeks between the groups receiving same treatment 
Table 
Table 1. Histomorphometric analysis of ectopic transplantation (mean±SD) 
 
Group 1 
(BCP) 
Group 2 
(BCP/BMP) 
Group 3 
(BCP/hPDLC) 
Group 4 
(BCP/hPDSC/BMP) 
Group 5 
(BCP/Har) 
Group 6 
(BCP/hPDLC/Har) 
2 weeks 0 0.08±0.09 0.01±0.03 0.16±0.06* † 0.04±0.01 0.13±0.11* 
8 weeks 0 2.24±1.81‡ 0.19±0.14‡ 6.65±4.76*†‡ 0.28±0.14‡ 2.13±1.13*‡ 
*satistically different compared to the group 1 
†statistically different compared to the group 3 
‡statistically different compared to 2 weeks 
